ApprovalTrail

Approval · Notice of Compliance 4503 · 1996

PRO-LECARB: Notice of Compliance 4503

Issued June 18, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4503
Date
June 18, 1996
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Antiparkinson agent

Products in this notice

BrandDINStatus today
PRO-LECARB02223287Cancelled Post Market
PRO-LECARB02223295Cancelled Post Market
PRO-LECARB02223309—

Medicinal ingredients